comparemela.com

Flushing Financial Corporation Reports 1Q22 GAAP EPS of $0.58 and Core EPS of $0.61

Flushing Financial Corporation Reports 1Q22 GAAP EPS of $0.58 and Core EPS of $0.61

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Flushing ,New York ,United States ,Uniondale ,Canada ,Brooklyn ,Long Island ,Johnr Buran ,Susank Cullen ,Acls Npls ,Empire Bancorp At ,Financial Corporation Nasdaq ,Financial Corporation ,Small Business Administration ,Company Annual Report On Form ,Exchange Commission ,Net Interest Income ,Interest Income ,Net Interest Margin ,Securities Exchange ,Paycheck Protection Program ,Home Loan Bank ,Wall Street ,Record Low Cost ,New York City ,Protection Program ,Record Level ,Business Loans ,Federal Reserve ,Stable Tangible Book Value Per ,Avg Loans ,Common Equity ,Total Assets ,Interest Margin ,Base Net Interest Income ,Fully Taxable Equivalent ,Tangible Assets ,Diluted Shares ,Loans And Deposits ,Call Information ,Chief Executive Officer ,Senior Executive Vice President ,Chief Financial Officer ,Live Call ,Access Code ,Release Date ,Second Quarter ,Flushing Bank ,New York State ,Equal Housing Lender ,Flushing Financial Corporation ,Private Securities Litigation Reform Act ,Press Release ,Securities Act ,Securities Exchange Act ,Annual Report ,Tables Follow ,Tangible Stockholder Common Equity ,Interest Income After Provision ,Before Provision ,Assets Yields ,Liabilities Yields ,Business Administration ,Empire Bancorp ,Average Rate ,Still Accruing ,Nonperforming Loans ,Nonperforming Assets ,Fair Value Adjustments ,Net Income ,Core Diluted ,Pre Provision Tax Net Revenue ,Core Net Interest Income ,Core Net Interest Margin ,Base Net Interest Margin ,Core Interest Income ,Total Loans ,Base Interest Income ,Core Noninterest Income ,Core Noninterest Expense ,Tangible Book Value ,Stockholder Common Equity ,Flushing Financial ,

comparemela.com © 2020. All Rights Reserved.